Microbiology News: clinical, Aug 2020

JAVASCRIPT DISABLED - This site works best with JavaScript enabled.

Microbiology News: clinical, Aug 2020

Assay Development Clinical Cosmetic/Personal Care Food & Beverage Laboratory Equipment Microbiome Other Pharmaceutical Veterinary Water

Effective Buccal Swab RNA Extraction for COVID-19 Diagnostic Testing

31 Aug 2020 | Clinical

RNA Extraction Buccal Swab Porvair COVID SARS

The Chromatrap^® Homogeniser Spin Column from Porvair Sciences has been adapted for COVID-19 to ensure an improved yield and quality of viral RNA from nasal and throat swab samples. more...

Abbott's Affordable BinaxNOW^™ COVID-19 Antigen Test Receives FDA Authorization

31 Aug 2020 | Clinical

Abbott's new antigen test to detect an active infection of SARS-CoV-2 in patients has been granted an FDA-EUA. Abbott claim the test has shown excellent diagnostic accuracy in studies and is very affordable at just $5 per test. A digital health pass (QR code) is available as standard. more...

Flu, RSV and SARS-CoV-2 Winter Test Panel Now Available in Europe

31 Aug 2020 | Clinical

SARS influenza RSV CE Primer Genesig Novacyt

The genesig® Winterplex Test panel can distinguish between SARS-CoV-2, Influenza A & B and RSV, requiring just one sample from the patient. Primerdesign's original SARS-CoV-2 assay was one of the first to be recommended by WHO to detect the virus. more...

EU Hospitals Deliver Sepsis Therapy Earlier with Rapid AST

28 Aug 2020 | Clinical

sepsis ast mic rapid drast antibiotic quantamatrix

Quantamatrix's dRAST™ platforms are now in 12 European hospital labs and private lab chains. dRAST platform offers Rapid Phenotypic MIC results interpreted in as little as four hours, enabling antibiotic therapy to be adapted for optimal patient and hospital use. more...

Yale and NBA Team-up for COVID-19 Game Changer

24 Aug 2020 | Clinical

Yale University has been granted EUA from the US FDA for its SalivaDirect COVID-19 testing protocol. The method is seen as a game-changer by many, as it avoids the use of reagents prone to global shortages and is a non-invasive technique, requiring only a saliva specimen. more...

New High Capacity Square Anaerobic Jar

19 Aug 2020 | Food & BeverageClinicalPharmaceuticalCosmetic/Personal CareMicrobiome

nox 18 SY Lab easiest high sample anaerobic jar

Small footprint – high sample capacity - nox.18 - the new square jar - making anaerobic incubation much simpler! more...

A Faster & Improved Microbiology Workflow Now Available in Europe

17 Aug 2020 | Clinical

The BD Kiestra™ InoqulA system is now available in Europe. This automated standalone microbiology workflow allows users to switch seamlessly between two modes to process liquid and non-liquid samples, and with the BD Synapsys™ informatics solution provides complete traceability. more...

RT-PCR & MALDI-TOF COVID-19 Assay Receives FDA Authorization

17 Aug 2020 | Clinical

Ethos Laboratories SARS-CoV-2 MALDI-TOF Assay has received FDA-EUA. The test utilizes both RT-PCR and ionization technology for the qualitative detection of viral RNA from a swab sample. The test is also authorized to take samples from Ethos At-home-Collection-kit. more...

UK Completes Assessment of COVID-19 Lateral-Flow IgG Kits

14 Aug 2020 | Clinical

The UK Government has published a peer-reviewed study on lateral-flow immunoassay (LFIA) COVID-19 kits that detect IgG only. LFIA were shown to have inferior sensitivity to ELISA but had high specificity, and were shown to be used competently by general public. more...

WHO Look to Improve COVID-19 Test Evaluation

13 Aug 2020 | Clinical

The World Health Organization has drafted new criteria on high volume and near-patient antibody and viral detection COVID-19 assays. The purpose of which is to improve its assessment of test kits on a case-by-case basis. Deadline for comments is 19 August. more...

FDA Authorizes First Semi-Quantitative COVID-19 IgG Serology Test

11 Aug 2020 | Clinical

siemens cov2g IgG semi quantitative FDA EUA

Siemens Healthineers has received FDA Emergency Use Authorization (EUA) for the SARS-CoV-2 IgG (COV2G) antibody test. It's the first semi-quantitative test offering sensitivity and specificity over 99% and enables clinicians to gauge levels of IgG in patient's blood sample. more...

New Mouse-Derived Monoclonal Antibodies for COVID-19 Research

10 Aug 2020 | Clinical

ViroStat has developed and released a set of new monoclonal antibodies to the nucleocapsid of the COVID-19 virus. These final 5 antibodies were selected from an initial group of 60 based upon highest binding affinity and best ELISA pairing for detection of native viral antigen. more...

COVID-19 Testing Lab is Granted FDA-EUA for Speedy Viral RNA Extraction Technique

10 Aug 2020 | Clinical

Quest Diagnostics has received FDA-EUA for a new viral RNA extraction technique that will increase its testing capacity to 185,000 per day. The method extracts RNA with the Mag-Bind Viral RNA Xpress Kit (Omega Bio-Tek) and the Hamilton MagEx STAR. more...

Dried Blood Spot Test Alleviates Constraints With COVID-19 Testing Says Perkin Elmer

10 Aug 2020 | Clinical

Perkin Elmer dried blood spot covid 19 gsp delfia igG

Perkin Elmer has launched a dried blood spot test for COVID-19 serology IgG testing. The finger-prick sample collection device allows for both decentralized sample collection and high-throughput testing. The product is CE-IVD marked and planned for US FDA-EUA. more...

High-Throughput COVID-19 Testing Enabled by Fluent Liquid Handling

10 Aug 2020 | ClinicalLaboratory Equipment

Thermo Fisher Scientific has introduced a new highly-automated, real-time PCR solution designed to analyze up to 6,000 samples in a single day. The modular solution delivers test results in a four-step process requiring minimal hands-on time, laboratory space and staffing resources. more...

Collect and Preserve Clinical Specimens Containing Viruses, Including SARS-CoV-2 (COVID-19)

06 Aug 2020 | Clinical

Liofilchem VTM is suitable for the collection and preservation of clinical specimens containing viruses, including SARS-CoV-2 (COVID-19), Chlamydia spp., Mycoplasma spp. and Ureaplasma spp. more...

Quantitative RUO COVID-19 ELISA Will Help Vaccine Developers

04 Aug 2020 | Clinical

RUO COVID-19 ELISA for Vaccine Developers

COVID-SeroIndex test kit is an ELISA assay, designed to measure the presence or absence of anti-COVID-19 antibodies in addition to measuring the titer of antibodies a person has produced. It utilizes not one, but two virus antigens: the full-length spike protein, and its receptor binding domain. more...

LabVantage COVID-19 LIMS Solution Implemented for Onsite Workplace Health and Safety

04 Aug 2020 | Clinical

The COVID-specific LIMS solution incorporates LabVantage’s deep knowledge of laboratory workflows, along with numerous features designed to make it easy for laboratories to perform coronavirus testing using RT-PCR, isothermal nucleic acid amplification, and serology methods. more...

FDA Recommendations for COVID-19 Diagnostics for Use In Non-Lab Settings

04 Aug 2020 | Clinical

COVID-19 Diagnostics for Non-Lab Settings

The FDA has posted a new template for commercial developers to help them submit EUA requests for COVID-19 diagnostic tests that can be performed entirely at home or in other settings besides a lab, such as offices or schools, and that could be available without a prescription. more...

RT-LAMP With Nanosequencing - LamPORE COVID-19 Testing to be Rolled Out by UK Government

03 Aug 2020 | Clinical

LamPORE is a precise, rapid, low-cost and highly scalable assay for the detection of SARS-CoV-2, designed to test saliva and swab RNA samples from either symptomatic or asymptomatic people. Using RT-LAMP to amplify specific viruses and nanopore sequencing to identify the amplified viruses. more...

Microbiologics Expands Viral Capabilities for SARS-CoV-2 With New BSL-3 Laboratory

03 Aug 2020 | Clinical

With new virology services capabilities, Microbiologics has launched a menu of cell-based services for SARS-CoV-2 to assist assay developers, evaluate therapeutic solutions and vaccines, and provide inactivated intact virus to researchers and diagnostic companies. more...

Self-Collected Saliva-based COVID-19 RT-PCR Test Receives FDA EUA

03 Aug 2020 | Clinical

The test, shown in CRL's EUA studies to be more sensitive and accurate than the standard COVID-19 anterior nasal swab test, detects the presence of coronavirus in the saliva of the test taker. more...

Detect 3 Different SARS-CoV-2 Antigens With xMAP^® Multi-Antigen IgG Assay - FDA EUA

03 Aug 2020 | Clinical

The xMAP SARS-CoV-2 Multi-Antigen IgG Assay demonstrated specificity of 100 percent in human serum and greater than 99 percent in human plasma, with sensitivity greater than 96 percent for both human serum and plasma (>14 days post-symptom onset) in clinical studies. more...

Visit Booth D37 at ECCMID to meet the MWE Team

Showcasing molecular diagnostic kits for clinical and food labs

Water Microbiology a rapidmicrobiology special focus

Get our eNewsletter